Xtant Medical completed the acquisition of nanOss production operations from RTI Surgical.

Xtant Medical, a medical technology company focused on surgical solutions for the treatment of spinal disorders, completed the acquisition of nanOss production operations from RTI Surgical, a leading CDMO in regenerative medicine. Financial terms were not disclosed. “nanOss is an important part of our total orthobiologics offering, and having full control over this product line enables us to begin the process of reviving and growing it. This deal satisfies each element of our acquisition criteria and positions us to improve our manufacturing capabilities, capacity and cash flows," Sean Browne, Xtant Medical CEO.